3 studies found for:    15284112 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Trial of Autologous CLL B Cells Transduced to Express Chimeric CD154 (ISF35)
Condition: Chronic Lymphocytic Leukemia
Intervention: Biological: ISF35
2 Completed A Phase I Extension Trial of Repeated Infusions of ISF35
Condition: Chronic Lymphocytic Leukemia
Intervention: Biological: ISF35
3 Unknown  FCM Versus R-FCM Followed by R-Maintenance or Observation Only
Conditions: Lymphoma, Follicular;   Lymphoma, Low-Grade;   Lymphoma, Intermediate-Grade
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Mitoxantrone;   Drug: Rituximab;   Procedure: chemotherapy: FCM;   Procedure: chemotherapy: R-FCM;   Procedure: maintenance therapy: Rituximab

Indicates status has not been verified in more than two years